Bio-Techne Corporation (TECH) has a consensus analyst rating of Buy, based on 25 analysts covering the stock. Of those, 18 recommend buying, 7 recommend holding, and 0 recommend selling.
The analyst consensus price target for TECH is $69.33, representing a +18.2% upside from the current price of $58.66. Price targets range from a low of $62.00 to a high of $79.00.
